Case-control analysis of nucleotide excision repair pathway and the risk of renal cell carcinoma

Carcinogenesis

Volumn 29, Issue 11, 2008, Pages 2112-2119

  Lin, Jie ^a   Pu, Xia ^a   Wang, Wei ^a   Matin, Surena ^a   Tannir, Nizar M ^a   Wood, Christopher G ^a   Wu, Xifeng ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; ASPARTIC ACID; XERODERMA PIGMENTOSUM GROUP A PROTEIN; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

5' UNTRANSLATED REGION; ADULT; AGE; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; EXCISION REPAIR; FEMALE; GENDER; GENETIC PREDISPOSITION; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HYPERTENSION; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CARCINOMA, RENAL CELL; CASE-CONTROL STUDIES; DNA REPAIR; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 56049116455     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn189     Document Type: Article

References (45)

1. Jemal,A. et al. (2008) Cancer statistics, 2008. CA Cancer J. Clin., 58, 71-96.
2. Setiawan,V.W. et al. (2007) Risk factors for renal cell cancer: the multiethnic cohort. Am. J. Epidemiol., 166, 932-940.
3. Lipworth,L. et al. (2006) The epidemiology of renal cell carcinoma. J. Urol, 176, 2353-2358.
4. Dhote,R. et al. (2000) Risk factors for adult renal cell carcinoma: A systematic review and implications for prevention. BJU Int., 86, 20-27.
5. Godschalk,R.W. et al. (2002) Body mass index modulates aromatic DNA adduct levels and their persistence in smokers. Cancer Epidemiol. Biomarkers Prev., 11, 790-793.
6. Rundle,A. et al. (2007) The association between benzo[a]pyrene-DNA adducts and body mass index, calorie intake and physical activity. Biomarkers, 12, 123-132.
7. Christmann,M. et al. (2003) Mechanisms of human DNA repair: An update. Toxicology, 193, 3-34.
8. Sancar,A. et al. (2004) Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu. Rev. Biochem., 73 39-85.
9. Wu,X. et al. (2006) Bladder cancer predisposition: A multigenic approach to DNA-repair and cell-cycle-control genes. Am. J. Hum. Genet., 78, 464-479.
10. Michiels,S. et al. (2007) Polymorphism discovery in 62 DNA repair genes and haplotype associations with risks for lung and head and neck cancers. Carcinogenesis, 28, 1731-1739.
11. Crew,K.D. et al. (2007) Polymorphisms in nucleotide excision repair genes, polycyclic aromatic hydrocarbon-DNA adducts, and breast cancer risk. Cancer Epidemiol. Biomarkers Prev., 16, 2033-2041.
12. Hirata,H. et al. (2006) Polymorphisms of DNA repair genes are associated with renal cell carcinoma. Biochem. Biophys. Res. Commun. 342, 1058-1062.
13. Sakano,S. et al. (2007) The association of DNA repair gene polymorphisms with the development and progression of renal cell carcinoma. Ann. Oncol., 18, 1817-1827.
14. Olson,S.H. et al. (1992) Evaluation of random digit dialing as a method of control selection in case-control studies. Am. J. Epidemiol., 135, 210-222.
15. Lin,J. et al. (2007) Mutagen sensitivity and genetic variants in nucleotide excision repair pathway: Genotype-phenotype correlation. Cancer Epidemiol. Biomarkers Prev., 16, 2065-2071.
16. Benjamini,Y. et al. (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B, 57, 289-300.
17. Zhang,H. et al. (1999) Recursive Partitioning in the Health Sciences. Springer, New York.
18. Wu,X. et al. (2003) XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity. Carcinogenesis, 24, 505-509.
19. Aboussekhra,A. et al. (1995) Mammalian DNA nucleotide excision repair reconstituted with purified protein components. Cell, 80 859-868.
20. Wood,R.D. (1999) DNA repair. Variants on a theme. Nature, 399 639-640.
21. He,Z. et al. (1995) RPA involvement in the damage-recognition and incision steps of nucleotide excision repair. Nature, 374, 566-569.
22. Li,L. et al. (1995) An interaction between the DNA repair factor XPA and replication protein A appears essential for nucleotide excision repair. Mol. Cell. Biol., 15, 5396-5402.
23. Kamiuchi,S. et al. (2002) Translocation of Cockayne syndrome group A protein to the nuclear matrix: Possible relevance to transcription-coupled DNA repair. Proc. Natl Acad. Sci. USA, 99 201-206.
24. De Boer,J. et al. (2000) Nucleotide excision repair and human syndromes. Carcinogenesis, 21, 453-460.
25. Wang,Y. et al. (2007) Nucleotide excision repair pathway genes and oral premalignant lesions. Clin. Cancer Res., 13, 3753-3758.
26. Hu,Z. et al. (2004) DNA repair gene XPD polymorphism and lung cancer risk: A meta-analysis. Lung Cancer, 46, 1-10.
27. Schabath,M.B. et al. (2005) Polymorphisms in XPD exons 10 and 23 and bladder cancer risk. Cancer Epidemiol. Biomarkers Prev., 14 878-884.
28. Park,J.Y. et al. (2002) Polymorphisms of the DNA repair gene xeroderma pigmentosum group A and risk of primary lung cancer. Cancer Epidemiol. Biomarkers Prev., 11, 993-997.
29. Aron,M. et al. (2008) Impact of gender in renal cell carcinoma: An analysis of the SEER database. Eur. Urol., 54, 133-142.
30. Böttner,A. et al. (2004) Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J. Clin. Endocrinol. Metab., 89, 4053-4061.
31. Horiguchi,A. et al. (2006) Increased serum leptin levels and over expression of leptin receptors are associated with the invasion and progression of renal cell carcinoma. J. Urol., 176, 1631-1635.
32. Naugler,W.E. et al. (2007) Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science, 317, 121-124.
33. Gago-Dominguez,M. et al. (2002) Lipid peroxidation: A novel and unifying concept of the etiology of renal cell carcinoma (United States). Cancer Causes Control, 13, 287-293.
34. Shapiro,J.A. et al. (1999) Hypertension, antihypertensive medication use, and risk of renal cell carcinoma. Am. J. Epidemiol. 5149, 521-530.
35. Toyokuni,S. et al. (1997) Induction of a wide range of C(2-12) aldehydes and C(7-12) acyloins in the kidney of Wistar rats after treatment with a renal carcinogen, ferric nitrilotriacetate. Free Radic. Biol. Med., 22, 1019-1027.
36. Toyokuni,S. et al. (1994) Formation of 4-hydroxy-2-nonenal-modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate. Proc. Natl Acad. Sci. USA, 91, 2616-2620.
37. Aaronson,S.A. (1991) Growth factors and cancer. Science, 254 1146-1153.
38. Kaaks,R. et al. (2001) Energy balance and cancer: The role of insulin and insulin-like growth factor-I. Proc. Nutr. Soc., 60 91-106.
39. Cheung,C.W. et al. (2004) The roles of IGF-I and IGFBP-3 in the regulation of proximal tubule, and renal cell carcinoma cell proliferation. Kidney Int., 65, 1272-1279.
40. Kellerer,M. et al. (1995) Insulin- and insulin-like growth-factor-I receptor tyrosine-kinase activities in human renal carcinoma. Int. J. Cancer, 62, 501-507.
41. Calle,E.E. et al. (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat. Rev. Cancer 4, 579-591.
42. Hall,J.E. et al. (1999) Mechanisms of hypertension and kidney disease in obesity. Ann. N. Y. Acad. Sci., 892, 91-107.
43. Jin,X. et al. (1995) Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype. Carcinogenesis, 16, 2205-2208.
44. Hazra,A. et al. (2003) Death receptor 4 and bladder cancer risk. Cancer Res., 63, 1157-1159.
45. Perera,F.P. et al. (2002) Associations between carcinogen-DNA damage, glutathione S-transferase genotypes, and risk of lung cancer in the prospective Physicians' Health Cohort Study. Carcinogenesis, 23, 1641-1646.